Nektar Therapeutics reported $1.37B in Assets for its second fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Assets Change
Agios Pharmaceuticals AGIO:US $ 1874.6M 613.83M
ALKERMES ALKS:US $ 1937.57M 59.35M
Amgen AMGN:US $ 59773M 2766M
Astrazeneca AZN:US $ 73641M 8715M
Baxter International BAX:US $ 19682M 216M
Biocryst Pharmaceuticals BCRX:US $ 277.28M 7.15M
Biogen BIIB:US $ 23806.7M 663.7M
Bluebird Bio BLUE:US $ 1454.46M 182.82M
Bristol Myers Squibb BMY:US $ 110797M 1638M
Cara Therapeutics CARA:US $ 221.45M 28.77M
Eisai 4523:JP Y 1129341M 39332M
Eli Lilly And LLY:US $ 47809M 970.7M
Esperion Therapeutics ESPR:US $ 280.46M 1.86M
Exelixis EXEL:US $ 2367.27M 176.73M
Gilead Sciences GILD:US $ 67984M 492M
GlaxoSmithKline GSK:LN 77011M 1068M
Halozyme Therapeutics HALO:US $ 1025.86M 59.28M
Immunogen IMGN:US $ 301.45M 44.52M
IONIS PHARMACEUT IONS:US $ 2497.07M 248.52M
Ironwood Pharmaceuticals IRWD:US $ 1007.22M 407.87M
Karyopharm Therapeutics KPTI:US $ 286.57M 11.66M
Macrogenics MGNX:US $ 425.91M 9.53M
Mirati Therapeutics MRTX:US $ 1355.7M 25.14M
Nektar Therapeutics NKTR:US $ 1371.35M 85.21M
Neurocrine Biosciences NBIX:US $ 1956.4M 110M
Novartis NOVN:VX SF 124015M 2263M
Sarepta Therapeutics SRPT:US $ 2759.07M 6.16M
Seattle Genetics SGEN:US $ 3952.16M 9.17M
Takeda 4502:JP Y 12657234M 255059M
Teva Pharmaceutical TEVA:IT 49.2B 191M
Xencor XNCR:US $ 695.6M 2.86M
YTE INCY:US $ 3904.62M 243.19M